Figure 3.

MEx therapy attenuates maternal renal pathology and hypertension. (A) Experimental design. (B) H&E histology of renal glomeruli at GD12, Images 100x magnification, scale bars 50um. Black arrows denote areas of eosin-positive proteinaceous material. (C) ELISA analysis of maternal urine albumin at GD12. (D) Maternal tail-cuff blood pressure throughout gestation. All images and graphical analyses representative of three independent experiments, three to four pregnant dams/experiment. Statistical significance (P < 0.05), as determined by one-way analysis of variance, denoted by different symbols (*,#,S).